L5W Stock Overview
A medical technology company, develops and markets non-invasive time-lapse imaging instruments in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Phase Holographic Imaging PHI AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.14 |
| 52 Week High | SEK 0.75 |
| 52 Week Low | SEK 0.13 |
| Beta | 0.99 |
| 11 Month Change | -59.15% |
| 3 Month Change | -73.54% |
| 1 Year Change | -69.47% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| L5W | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.3% | -1.0% | -0.02% |
| 1Y | -69.5% | -7.3% | 8.2% |
Return vs Industry: L5W underperformed the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: L5W underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| L5W volatility | |
|---|---|
| L5W Average Weekly Movement | 19.5% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L5W's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L5W's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 12 | Anders Mansson | phiab.com |
Phase Holographic Imaging PHI AB (publ), a medical technology company, develops and markets non-invasive time-lapse imaging instruments in Sweden and internationally. The company’s products include HoloMonitor M4, a live cell imaging system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor for single cell tracking, kinetic dose response and cell motility, cell morphology, wound healing, cell quality control, cell counter, and kinetic cell proliferation assay. It also offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics and interior of HoloMonitor free from condensation.
Phase Holographic Imaging PHI AB (publ) Fundamentals Summary
| L5W fundamental statistics | |
|---|---|
| Market cap | €14.71m |
| Earnings (TTM) | -€21.80m |
| Revenue (TTM) | €9.12m |
0.0x
P/S Ratio0.0x
P/E RatioIs L5W overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L5W income statement (TTM) | |
|---|---|
| Revenue | SEK 9.12m |
| Cost of Revenue | SEK 2.64m |
| Gross Profit | SEK 6.48m |
| Other Expenses | SEK 28.29m |
| Earnings | -SEK 21.80m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 19, 2024
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 71.06% |
| Net Profit Margin | -239.04% |
| Debt/Equity Ratio | -2,535.9% |
How did L5W perform over the long term?
See historical performance and comparison